Overview
Janashakthi Insurance is a Sri Lankan life and health insurer, earning premiums from individual and group policies while managing an investment portfolio to support underwriting obligations. The central change is not premium volume but earnings quality: the latest filed quarter retained very little of revenue as profit, while the company-reported nine-month update shows premium growth continuing.
Price performance
At LKR 38.20 on 16 November 2026, the share was down 28.9% over one year against a 6.9% fall in the ASPI, showing a much weaker record than the market over that window. It stood 27.1% of the way up its 52-week range, closer to the low than the high.
Trading has become busier and more variable than its own recent record: 60-day annualised volatility was 45.4%, above the 41.4% one-year reading, while 20-day volume was 60.2% above the prior 60-day level. The three-year record contains four falls of 15% or more, the deepest 42%, which has not yet recovered. Liquidity is limited: a LKR 1 million order is about 82% of what trades on a typical day, a large part of a day's trading.
The 1:3 share split took effect on 9 April 2026. Returns are restated to today's share basis, while older per-share figures before the split need dividing by three for comparison; the split did not change the size of the company.
Valuation
The share trades on a P/E of 8.0 times, meaning LKR 8 for every LKR 1 of trailing profit, and sits at the 14th percentile of insurance peers on that measure. Its P/B is 1.54 times, or LKR 1.54 for each LKR 1 of net assets, and the premium to book is less easily justified by a trailing ROE of 4.7%.
The sector comparison and own record diverge. Today's P/B is more expensive than 68% of days since January 2019, so the share is inexpensive against sector earnings multiples but not against its own book-value history. The latest quarter supplied only 3.5% of trailing EPS; at its year-ago net margin, the same price would equate to 3.6 times earnings rather than the current multiple, showing how sharply the latest result reduced the profit underlying the valuation.
The 8.7% trailing dividend yield accompanies a payout of 69.9% of earnings and 1.43 times dividend cover. Dividends rose from LKR 4.41 in FY2023 to LKR 5.00 in FY2025 on today's share basis, but the LKR 10.00 second interim dividend's ex-date was 24 December 2025, so a buyer today does not receive it.
News and sentiment
Company coverage was normal over the past 90 days, with three material articles split evenly between positive, negative and neutral tone. Janashakthi reported on 16 November that nine-month gross written premiums to 30 September 2026 rose 21% to LKR 7.4 billion, while profit before tax was LKR 391 million; it attributed the profitability pressure to lower investment income and mark-to-market losses as policy rates changed.
An earlier report on 14 August cited 36% first-half premium growth and LKR 271 million of profit before tax. These reported operating updates support continued premium expansion, but also confirm that investment-market movements have become the main restraint on earnings.
Financials
September-quarter revenue fell 30.4% year-on-year to LKR 3.0 billion and net profit fell 98.1% to LKR 29 million. Net margin contracted from 34.3% to 1.0%, meaning the company retained roughly one cent of profit from each rupee of revenue versus 34 cents a year earlier. That September net margin ranked sixth out of seven comparable September quarters, among the weakest results on record.
Gross and operating margins are not available for either September quarter, so no comparable movement can be stated for those measures. The latest twelve months to September 2026 produced LKR 12.8 billion of revenue, down 18.5%, and a 5.6% net margin. The latest audited year, 2025, had a 25.2% net margin and net profit fell 23.2%, establishing that the pressure pre-dated the September quarter.
Equity was LKR 16.8 billion at September. The balance sheet used 679.6 million shares, whereas the March filing used 226.5 million before the April subdivision; EPS movements across those filings are therefore mechanically affected by the tripling of the share count as well as by profit performance.
Risks
The largest risk is the sharp loss of profitability from investment-market effects. The latest quarter's 1.0% net margin was far below the 34.3% year-ago result, and the company's 16 November update specifically linked lower profitability to lower investment income and mark-to-market losses on policy-rate changes.
As an insurer, liabilities were 1.43 times equity at the latest audited year, up from 1.24 times a year earlier. This means the business carried LKR 1.43 of liabilities, including policy obligations, for every LKR 1 of equity, making capital and asset-liability management important if earnings remain weak.
The market backdrop adds portfolio uncertainty. Falling secondary government-bond yields can affect fixed-income portfolio valuations and reinvestment yields across the insurance sector, although the supplied sector evidence does not establish the effect on Janashakthi specifically. Limited trading liquidity is a separate practical risk for anyone seeking to build or exit a sizeable position.
Outlook
As at 16 November 2026, the next scheduled catalyst is the audited year-end filing for 31 December 2026, expected between 28 April and 3 June 2027. It will show whether premium growth and the investment portfolio restored earnings after the weak September quarter, or whether the reported investment-income pressure persisted.
The available data cannot separate underwriting profitability from investment-market effects in the latest quarter because operating-profit and gross-profit figures are absent. The filing will therefore be more informative than the current P/E alone, particularly on whether the low trailing multiple reflects recurring insurance earnings or a profit base that has materially weakened.